The safety assessment is based on the independent safety profiles of each compound (GLP-1 medications through extensive FDA trials, BPC-157 through decades of preclinical research), their non-overlapping mechanisms, and growing clinical experience from physicians who prescribe both
On timeline, NAD+ effects can be felt relatively quickly for some people, while many peptide driven changes build gradually
Microbial ecology: human gut microbes associated with obesity (in Eng)
The other 2 said about 80% of their symptoms improved
Both intermittent dosing schedules (injections on specific days) and continuous daily administration showed benefits, suggesting some flexibility in protocol design
The technique below assumes you are working with a lyophilized research peptide and pharmaceutical-grade bacteriostatic water for injection